Table 1.
Baseline characteristics of MMD patients treated with RIC
| Characteristics | Number of patients (n = 30) | (%) |
|---|---|---|
| Demographics | ||
| Female | 12 | 40.0 |
| Male | 18 | 60.0 |
| Age, years | 22.0 ± 17.6 | NA |
| Adult | 12 | 40.0 |
| Child | 18 | 60.0 |
| Smoke | 2 | 6.7 |
| Drink | 2 | 6.7 |
| Clinical manifestations | ||
| Time from symptom onset to enrollment, months | 6.0 (3.5, 23.2) | NA |
| Follow‐up time | 16.8 (6.8, 24.0) | NA |
| TIA | 18 | 60.0 |
| Headache | 9 | 30.0 |
| Dizziness | 2 | 6.7 |
| Paralysis | 19 | 63.3 |
| Paresthesia | 3 | 10.0 |
| Visual disorder | 3 | 10.0 |
| Aphasia | 4 | 13.3 |
| Comorbid disease | ||
| Hypertension | 4 | 13.3 |
| Diabetes | 2 | 6.7 |
| Hyperlipemia | 2 | 6.7 |
| Comorbid disease free | 24 | 80.0 |
| Imaging findings | ||
| Unilateral stenosis | 3 | 10.0 |
| Bilateral stenosis | 27 | 90.0 |
| Stenosis position | ||
| Left distal ICA | 16 | 53.3 |
| Right distal ICA | 16 | 53.3 |
| Left MCA | 24 | 80.0 |
| Right MCA | 26 | 86.7 |
| Left ACA | 15 | 50.0 |
| Right ACA | 12 | 40.0 |
| Left PCA | 4 | 13.3 |
| Right PCA | 3 | 10.0 |
| Modified Suzuki scoring | ||
| Stage I | 6 | 20.0 |
| Stage II | 6 | 20.0 |
| Stage III | 9 | 30.0 |
| Stage IV | 9 | 30.0 |
| Brain tissue infarction | 12 | 40.0 |
Continuous variates following a Gaussian distribution were presented as mean ± standard deviation; otherwise, the vairates were presented as median (interquartile range, IQR). Categorical data were expressed as n (%).